Robert F Day

New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.

D. Scott, P. Iredale, S. Sakya, 2006, Bioorganic & medicinal chemistry letters.

Excretion, Metabolism, and Pharmacokinetics of CP-945,598, a Selective Cannabinoid Receptor Antagonist, in Rats, Mice, and Dogs

C. Prakash, D. Scott, D. Griffith, 2011, Drug Metabolism and Disposition.

Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists.

B. Lefker, R. Chesworth, T. Owen, 2004, Bioorganic & medicinal chemistry letters.

Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity.

T. Maurer, D. Hargrove, D. Tess, 2007, Bioorganic & medicinal chemistry letters.

Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.

Margaret S. Landis, D. Scott, P. Iredale, 2009, Journal of medicinal chemistry.